United Therapeutics Corporation
UTHRNASDAQ
USReal-Time Price
USReal-Time Price$553.88USD
+10.73 (+1.98%)Today
$569.90+16.02 (+2.89%)Pre-Market7:06 AM ET
BTI Score
Near Future
63
Long Term
70
BTI Fair Market Cap
$26.89B
-11.67% vs fair
Biotechnology
Buy
United Therapeutics Corporation (UTHR) Valuation
Is United Therapeutics Corporation (UTHR) overvalued or undervalued? BTI's fair-value estimate, DCF model and valuation multiples show the premium or discount to intrinsic worth.
Valuation Snapshot
P/E (TTM)
Trailing Price-to-Earnings
18.23
Forward P/E
Next 12 months estimate
17.29
PEG Ratio
P/E to Growth ratio
—
Price / Sales
Market cap vs. revenue
—
Price / Book
Market cap vs. book value
—
EV / EBITDA
Enterprise value multiple
—
Earnings Yield
Inverse of P/E
5.49%
Revenue Growth
Year-over-year
—
Valuation Risk
United Therapeutics Corporation's valuation multiples are within a moderate range, suggesting the market is not pricing in excessive optimism. Investors should monitor growth execution relative to valuation.
Run Full Valuation Model
DCF, multiples, scenario analysis and AI fair value for UTHR